Corey Momont

Title: Corey Momont: Innovator in Genetic Engineering

Introduction

Corey Momont is a prominent inventor based in New York, NY (US), known for his contributions to genetic engineering. He holds a total of 6 patents, showcasing his innovative approach to biotechnology and molecular biology.

Latest Patents

Among his latest patents is a method for nuclease-mediated DNA assembly. This method involves using a sequence-specific nuclease agent, such as a gRNA-Cas complex, to assemble nucleic acids with overlapping complementary sequences. The technique allows for the creation of double-strand breaks in dsDNA or nicks on each strand, facilitating the assembly of nucleic acids with or without complementary ends. Another significant patent involves genetically modified mice that express humanized immunoglobulin heavy chain constant region genes. This invention provides methods and compositions for in vivo testing of therapeutic agents, enabling researchers to evaluate pharmacokinetic and pharmacodynamic properties in genetically modified rodents.

Career Highlights

Corey Momont is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to advance his research in genetic engineering and therapeutic development. His work has significant implications for the field of medicine, particularly in the development of humanized therapies.

Collaborations

Corey collaborates with notable colleagues, including John R McWhirter and Lynn Macdonald, who contribute to his innovative projects and research initiatives.

Conclusion

Corey Momont's work in genetic engineering exemplifies the intersection of innovation and biotechnology. His patents and ongoing research at Regeneron Pharmaceuticals, Inc. highlight his commitment to advancing medical science through innovative solutions.